Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00834600Phase 4Completed
A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Louis and Rachel Rudin Foundation. Started Dec 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00834600.